New insider Lopriore Vincent S claimed ownership of 732,424 shares (SEC Form 3)
$THAR
Biotechnology: Pharmaceutical Preparations
Health Care
| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 04/09/2025 |
3. Issuer Name and Ticker or Trading Symbol
Tharimmune, Inc. [ THAR ] |
|||||||||||||
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Common Stock | 732,424 | I | By Gravitas Capital LP(1) |
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Stock Option (right to buy) | (2) | 08/04/2035 | Common Stock | 100,000 | $1.33 | D | |
| Series A Warrants (right to buy) | 12/20/2025 | 12/20/2030 | Common Stock | 337,838 | $1.29 | I | See Footnote(1) |
| Series B Warrants (right to buy) | 12/20/2025 | 12/20/2030 | Common Stock | 168,918 | $3 | I | See Footnote(1) |
| Common Stock Purchase Warrants | 06/09/2025 | 06/09/2030 | Common Stock | 443,806 | $2.03 | I | See Footnote(1) |
| Explanation of Responses: |
| 1. The reported shares are owned directly by Gravitas Capital LP, a limited partnership of which Gravitas Capital Partners LLC is the sole general partner. The reporting person is the managing member of Gravitas Capital Partners LLC. The reporting person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein. |
| 2. 50,000 of the options vest on date of grant and 50,000 vest on August 4, 2026. |
| /s/ Vincent S. LoPriore | 08/20/2025 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||